Description:

MLNK is the ticker symbol for Mallinckrodt plc (formerly known as Covidien plc), a company listed on the New York Stock Exchange. The company operates in various segments including specialty pharmaceuticals and diagnostic imaging. Mallinckrodt has been recognized for its focus on developing innovative therapies and diagnostic solutions aimed at addressing unmet medical needs in areas such as pain management, hemophilia, and other rare and orphan diseases. Investors interested in this stock should consider the company's strategic initiatives, financial performance, and market position within its industry sectors.

Data:

Yields: